ATE438625T1 - Quaternäre 3-amido, n-methylpyridiniumsalze als entzündungshemmende mittel - Google Patents

Quaternäre 3-amido, n-methylpyridiniumsalze als entzündungshemmende mittel

Info

Publication number
ATE438625T1
ATE438625T1 AT06804891T AT06804891T ATE438625T1 AT E438625 T1 ATE438625 T1 AT E438625T1 AT 06804891 T AT06804891 T AT 06804891T AT 06804891 T AT06804891 T AT 06804891T AT E438625 T1 ATE438625 T1 AT E438625T1
Authority
AT
Austria
Prior art keywords
inflammatory
compounds
amido
quaternary
anion
Prior art date
Application number
AT06804891T
Other languages
English (en)
Inventor
Jacques Gosteli
Original Assignee
Cerecon Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cerecon Ag filed Critical Cerecon Ag
Application granted granted Critical
Publication of ATE438625T1 publication Critical patent/ATE438625T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • C07D213/82Amides; Imides in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
AT06804891T 2005-12-09 2006-11-29 Quaternäre 3-amido, n-methylpyridiniumsalze als entzündungshemmende mittel ATE438625T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH19542005 2005-12-09
PCT/CH2006/000672 WO2007065281A1 (en) 2005-12-09 2006-11-29 Quaternary 3 -amido, n-methylpyridinium salts as anti -inflammatory agents

Publications (1)

Publication Number Publication Date
ATE438625T1 true ATE438625T1 (de) 2009-08-15

Family

ID=37913716

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06804891T ATE438625T1 (de) 2005-12-09 2006-11-29 Quaternäre 3-amido, n-methylpyridiniumsalze als entzündungshemmende mittel

Country Status (7)

Country Link
US (1) US20080249140A1 (de)
EP (1) EP1963270B1 (de)
AT (1) ATE438625T1 (de)
CA (1) CA2629913A1 (de)
DE (1) DE602006008349D1 (de)
MX (1) MX2008007259A (de)
WO (1) WO2007065281A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3191082A1 (de) * 2014-09-10 2017-07-19 Novartis Consumer Health S.A. Topische diclofenac-natrium-zusammensetzungen
US20190282560A1 (en) * 2016-07-18 2019-09-19 Pharmena S.A. 1-Methylnicotinamide for the Treatment of Diseases Associated With C-Reactive Protein
EP3592336A1 (de) 2017-03-07 2020-01-15 Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd. Topische verabreichungssysteme für wirkstoffe

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3340028A1 (de) * 1983-11-03 1985-05-15 Josef Dipl.-Chem. Dr.Rer.Nat. Klosa Neues salicylsaeuresalz
PL190755B1 (pl) * 1999-01-07 2006-01-31 Pharmena Sp Z Oo Preparat do leczenia i profilaktyki chorób skóry
PL364348A1 (en) * 2004-01-12 2005-07-25 PHARMENA Sp.z o.o. Application of quaternary pyridine salts as vessel protection agent

Also Published As

Publication number Publication date
EP1963270A1 (de) 2008-09-03
US20080249140A1 (en) 2008-10-09
DE602006008349D1 (de) 2009-09-17
MX2008007259A (es) 2008-09-23
CA2629913A1 (en) 2007-06-14
EP1963270B1 (de) 2009-08-05
WO2007065281A1 (en) 2007-06-14

Similar Documents

Publication Publication Date Title
BR112014009910A2 (pt) formulações de sal de meglumina de ácido 1-(5,6-dicloro-1h-benzo[d]imidazol-2-il)-1h-pirazol-4-carboxílico
GT200600496A (es) Sales, profarmacos y formulaciones de 1-[5-(4-amino-7-isopropil-7h-pirrolo[2,3-d]piirimidin-5-carbonil)-2-metoxi-feil]-3-(2,4-dicloro-fenil)-urea.
CY1115058T1 (el) Παραγωγα 1,2,3- τριαζολης για χρηση ως αναστολεις στεατοϋλο-coa δεσατουρασης
AR080491A1 (es) Formulaciones orales y sales lipofilicas de metilnaltrexona
UA108363C2 (uk) Похідні імінотіадіазиндіоксиду як інгібітори bace, композиція на їх основі і їх застосування
BRPI0612287A8 (pt) composição para uso farmacêutico no tratamento de doenças através da medicina nuclear e métodos de uso e para modulação de atividade de receptor nuclear
DK2324008T3 (da) Diarylpyrazol som protein kinase inhibitorer
UY29791A1 (es) Sales novedosas de lisina de derivados de acido 4-( (fenoxialquil)tio)-fenoxiacetico
GT200600163A (es) Nuevas combinaciones terapeuticas para el tratamiento o la prevencion de la depresion
DE50101364D1 (de) Ortho substituierte anthranilsäureamide und deren verwendung als arzneimittel
BRPI0408486A (pt) derivados de biciclopirazol ativos como inibidores da cinase, processo para a sua preparação e composições farmacêuticas compreendendo-os
JP2012144490A (ja) 外用組成物
BRPI0607614A2 (pt) sal de besilato da 7-(2-(4-3-trifluorometil-fenil)-1,2,3,6-tetrahidropirid- 1-il)etil) isoquinoleìna, o respectivo medicamento, composição farmacêutica e uso
BR112014028813A2 (pt) 5-amino[1,4]tiazinas como inibidores bace1
UY30029A1 (es) Derivados de piperidina, sus sales farmacéuticamente aceptables, composiciones farmacéuticas conteniéndolos y aplicaciones
NO20084478L (no) Konjugerte lipidderivater
BRPI0411122A (pt) pirazol[3,4-b]piridin-6-onas como inibidores gsk-3
ATE438625T1 (de) Quaternäre 3-amido, n-methylpyridiniumsalze als entzündungshemmende mittel
NO20023551D0 (no) Ibuprofen-inneholdende aktivt middel-preparat
BRPI0607918A2 (pt) tetraidro-piridoazepin-8-onas e compostos relacionados para o tratemento da esquizofrenia.
PL1868631T3 (pl) Zastosowanie związków indukujących syntezę białek SIRT przy lub dla otrzymywania kompozycji kosmetycznej lub farmaceutycznej
WO2008074833A3 (en) Compounds
HRP20060079B1 (en) Benzoquinolizine-2-carboxylic acid arginine salt tetrahydrate
Li et al. Synthesis and antitumor evaluation of a highly potent cytotoxic DNA cross-linking polyamine analogue, 1, 12-diaziridinyl-4, 9-diazadodecane
EA201000701A1 (ru) 4-[4-(2-адамантилкарбамоил)-5-трет-бутилпиразол-1-ил]бензойная кислота-465

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties